Assessing decreased sensation and increased sensory phenomena in diabetic polyneuropathies

Diabetes

Volumn 62, Issue 11, 2013, Pages 3677-3686

  Dyck, Peter J ^a   Herrmann, David N ^b   Staff, Nathan P ^a   Dyck, P James B ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY SURFACE; CLINICAL FEATURE; DIABETIC NEUROPATHY; DISEASE MARKER; DISEASE SEVERITY; FOOT; HEAT SENSATION; HUMAN; HYPERALGESIA; MAGNITUDE ESTIMATION METHOD; NERVE CONDUCTION; NERVE ENDING; NERVE FIBER; NERVE POTENTIAL; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROPATHY IMPAIRMENT SCORE; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NERVE; PRESSURE; PRIORITY JOURNAL; QUANTITATIVE SENSORY TESTING; QUANTITATIVE STUDY; REVIEW; SCREENING TEST; SENSATION; SENSORY ANALYSIS; SENSORY NERVE; STIMULUS RESPONSE; SYMPTOM ASSESSMENT; TOUCH; VIBRATION; ADULT; AGED; DIABETIC NEUROPATHIES; ELECTRODIAGNOSIS; FEMALE; MALE; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; METHODOLOGY; PAIN ASSESSMENT;

ADULT; AGED; DIABETIC NEUROPATHIES; ELECTRODIAGNOSIS; FEMALE; FOOT; HUMANS; HYPERALGESIA; MALE; NERVE FIBERS; NEURAL CONDUCTION; PAIN MEASUREMENT;

EID: 84891688083     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0352     Document Type: Review

References (90)

1. Tesfaye S, Boulton AJ, Dyck PJ, et al.; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33: 2285-2293
2. Dyck PJ, Albers JW, Andersen H, et al.; on behalf of the Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011;37:620-628
3. Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 1983;46:491-499
4. Lawson SN. The Peripheral Sensory Nervous System: Dorsal Root Ganglion Neurons. In Peripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Elsevier, 2005, p. 163-202
5. Dyck PJ, O'Brien PC, Johnson DM, Klein CJ, Dyck PJB. Quantitative Sensation Testing. In Peripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Elsevier, 2005, p. 1063-1094
6. Lambert EH, Dyck PJ. Compound Action Potentials of Sural Nerve in Vitro in Peripheral Neuropathy. In Peripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Elsevier, 2005, p. 1015-1028
7. Dyck PJ, Karnes JL, O'Brien PC, Okazaki H, Lais A, Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol 1986;19:440-449
8. Dyck PJB, Engelstad J, Norell J, Dyck PJ. Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J Neuropathol Exp Neurol 2000;59:525-538
9. Dyck PJ, Zimmerman IR, Johnson DM, et al. A standard test of heat-pain responses using CASE IV. J Neurol Sci 1996;136:54-63
10. Dyck PJ, Hughes RAC, O'Brien PC. Quantitating Overall Neuropathic Symptoms, Impairments, and Outcomes. In Peripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Elsevier, 2005, p. 1031-1052
11. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289
12. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001;24:250-256
13. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002;25:2048-2052
14. Dyck PJ, Overland CJ, Low PA, et al.; Cl vs. NPhys Trial Investigators. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve 2010;42: 157-164
15. Dyck PJ, Overland CJ, Low PA, et al. "Unequivocally abnormal" vs "usual" signs and symptoms for proficient diagnosis of diabetic polyneuropathy: Cl vs N Phys Trial. Arch Neurol 2012;69:1609-1614
16. Eloesser L. On the nature of neuropathic affections of the joints. Ann Surg 1917;66:201-207
17. Corbin KB, Hinsey JC. Influence of the nervous system on bone and joints. Anat Rec 1939;75:307-317
18. Harris JR, Brand PW. Patterns of disintegration of the tarsus in the anaesthetic foot. J Bone Joint Surg Br 1966;48:4-16
19. Dyck PJ, Stevens JC, O'Brien PC, et al. Neurogenic arthropathy and recurring fractures with subclinical inherited neuropathy. Neurology 1983; 33:357-367
20. Boulton AJM. Peripheral neuropathy and the diabetic foot. Foot 1992;2: 67-72
21. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36: 150-154
22. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994;17:557-560
23. British Diabetic Association. What Diabetic Care to Expect. London, BDA, 1990
24. American Diabetes Association. Position statement. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1993;17:616-623
25. Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia 1992;35:660-663
26. Kuipers M, Schreuders T. The predictive value of sensation testing in the development of neuropathic ulceration on the hands of leprosy patients. Lepr Rev 1994;65:253-261
27. Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995;18:34-38
28. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther 1996;76:68-71
29. Valk GD, Kriegsman DM, Assendelft WJ. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev 2001 (4):CD001488
30. Abbott CA, Carrington AL, Ashe H, et al.; North-West Diabetes Foot Care Study. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002;19:377-384
31. Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 2002;25:2010- 2015
32. Boulton AJM. The Diabetic Foot. In Textbook of Diabetic Neuropathy. Gries FA, Low PA, Cameron NE, Ziegler D, Eds. New York, Thieme, 2003, p. 295-305
33. Lyder CH. Pressure ulcer prevention and management. JAMA 2003;289: 223-226
34. Boulton AJM, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 2004;351:48-55
35. Crawford F, Inkster M, Kleijnen J, Fahey T. Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. QJM 2007;100: 65-86
36. Lavery LA, Higgins KR, Lanctot DR, et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a selfassessment tool. Diabetes Care 2007;30:14-20
37. Peters EJ, Armstrong DG, Lavery LA. Risk factors for recurrent diabetic foot ulcers: site matters. Diabetes Care 2007;30:2077-2079
38. Boulton AJ. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 2008;24(Suppl. 1):S3-S6
39. Dyck PJ, Norell JE, Tritschler H, et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care 2007;30:2619-2625
40. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract 2001;54:115-128
41. Perkins BA, Grewal J, Ng E, Ngo M, Bril V. Validation of a novel pointof- care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care 2006;29:2023-2027
42. Dyck PJ, Winkler JA, Andrews KL, Kavros SJ, Vella A, Davies JL. Testing of touch-pressure sensation: introduction of the touch-pressure sensogram. In Companion to Peripheral Neuropathy. Illustrated Cases and New Developments. Dyck PJ, Dyck PJB, Engelstad JK, et al., Eds. Philadelphia, Saunders Elsevier, 2010, p. 327-329
43. Dyck PJ, Albers JW, Wolfe J, et al.; the Clinical vs. Neurophysiology Trial 3 Investigators. A trial of proficiency of nerve conduction: greater standardization still needed. Muscle Nerve 2013;48:369-374
44. Backonja MM, Attal N, Baron R, et al. Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 2013;154: 1807-1819
45. Dyck PJ, Hansen JD, Winkler JA, Witt LV, Davies JL. Thermal disk quantitative sensation testing of cooling discrimination. In Companion to Peripheral Neuropathy. Illustrated Cases and New Developments. Dyck PJ, Dyck PJB, Engelstad JK, et al., Eds. Philadelphia, Saunders Elsevier, 2010, p. 331-333
46. Kimura J. Nerve Conduction and Needle Electromyograpy. In Peripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Elsevier, 2005, p. 899-970
47. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43:817-824
48. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O'Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999;22:1479-1486
49. American Diabetes Association; American Academy of Neurology. Consensus statement: report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes Care 1988;11:592-597
50. England JD, Gronseth GS, Franklin G, et al.; American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005;64:199-207
51. Behse F, Buchthal F, Carlsen F. Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 1977;40:1072- 1082
52. England JD, Gronseth GS, Franklin G, et al. Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Arch Phys Med Rehabil 2005;86:167-174
53. Dyck PJ, Carter RE, Litchy WJ. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve 2011;44:340-345
54. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 1996;47:1042-1048
55. Kennedy WR, Wendelschafer-Crabb G, Polydefkis M, McArthur JC. Pathology and quantitation of cutaneous innervation. In Peripheral Neuropathy. 4th ed. Dyck PJ, Thomas PK, Eds. Philadelphia, Elsevier, 2005, p. 869-895
56. McCarthy BG, Hsieh ST, Stocks A, et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995;45:1848-1855
57. Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999;53:1634-1640
58. England JD, Gronseth GS, Franklin G, et al.; American Academy of Neurology. Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009;72: 177-184
59. Dyck PJ, Winkelmann RK, Bolton CF. Quantitation of Meissner's corpuscles in hereditary neurologic disorders. Charcot-Marie-Tooth disease, Roussy-Levy syndrome, Dejerine-Sottas disease, hereditary sensory neuropathy, spinocerebellar degenerations, and hereditary spastic paraplegia. Neurology 1966;16:10-17
60. Nolano M, Provitera V, Crisci C, et al. Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann Neurol 2003;54:197-205
61. Lauria G, Bakkers M, Schmitz C, et al. Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 2010;15:202-207
62. Engelstad JK, Taylor SW, Witt LV, et al. Epidermal nerve fibers: confidence intervals and continuous measures with nerve conduction. Neurology 2012;79:2187-2193
63. Umapathi T, Tan WL, Loke SC, Soon PC, Tavintharan S, Chan YH. Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve 2007;35:591-598
64. Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 2004;127:1593-1605
65. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2010;15:79-92
66. Navarro X, Sutherland DE, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997;42:727-736
67. Smith AG, Russell J, Feldman EL, et al. Lifestyle intervention for prediabetic neuropathy. Diabetes Care 2006;29:1294-1299
68. Herrmann DN, McDermott MP, Henderson D, Chen L, Akowuah K, Schifitto G; North East AIDS Dementia (NEAD) Consortium. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve 2004;29:420-427
69. Lauria G, Morbin M, Lombardi R, et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 2003;61:631-636
70. Gibbons CH, Griffin JW, Polydefkis M, et al. The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology 2006;66:256-258
71. Facer P, Casula MA, Smith GD, et al. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol 2007;7:11
72. Narayanaswamy H, Facer P, Misra VP, et al. A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies. J Clin Neurosci 2012;19:1490-1496
73. Lauria G, Borgna M, Morbin M, et al. Tubule and neurofilament immunoreactivity in human hairy skin: markers for intraepidermal nerve fibers. Muscle Nerve 2004;30:310-316
74. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000; 23:399-409
75. Krishnan AV, Kiernan MC. Altered nerve excitability properties in established diabetic neuropathy. Brain 2005;128:1178-1187
76. Sung JY, Park SB, Liu YT, et al. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes. Diabetes 2012;61:1592-1598
77. Arnold R, Kwai N, Lin CS, Poynten AM, Kiernan MC, Krishnan AV. Axonal dysfunction prior to neuropathy onset in type 1 diabetes. Diabetes Metab Res Rev 2013;29:53-59
78. Mitchell SW, Morehouse GR, Keen WW. Gunshot Wounds and other Injuries of Nerves. Philadelphia, J.B. Lippincott & Co., 1864
79. Mitchell SW. Injuries of Nerves and Their Consequences. Philadelphia, J.B. Lippincott & Co., 1872
80. Rivers WHR, Head H. A human experiment in nerve division. In Studies in Neurology. Head H, Ed. London, Oxford University Press, 1920, p. 225-329
81. Dyck PJ, Lofgren EP. Method of fascicular biopsy of human peripheral nerve for electrophysiologic and histologic study. Mayo Clin Proc 1966;41: 778-784
82. Wall PD, Gutnick M. Properties of afferent nerve impulses originating from a neuroma. Nature 1974;248:740-743
83. Wall PD, Devor M, Inbal R, et al. Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain 1979;7:103-111
84. Wall PD, Devor M. Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and nerve injured rats. Pain 1983;17:321-339
85. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820
86. Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol 2002;50:205-228
87. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG. From genes to pain: Na v 1.7 and human pain disorders. Trends Neurosci 2007;30:555-563
88. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology 2012;79:1136-1144
89. Dyck PJ, Peroutka S, Rask C, et al. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 1997;48:501-505
90. Bierhaus A, Fleming T, Stoyanov S, et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nat Med 2012;18:926-933